Titzepatide

Tirzepatide is a dual-agonist peptide studied for its effects on metabolic regulation and energy balance pathways. In research settings, Tirzepatide is designed to activate both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, which play key roles in glucose metabolism, appetite signaling, and insulin response. Laboratory investigations explore its influence on metabolic efficiency, nutrient utilization, and hormonal pathways involved in energy homeostasis. Due to its multi-pathway activity, Tirzepatide remains an important compound in metabolic and endocrine research models. This peptide is supplied strictly for laboratory and scientific research purposes only and is not approved for human consumption.